A First-in-Class HBO1 Inhibitor WM-3835 Inhibits Castration-Resistant Prostate Cancer Cell Growth In Vitro and In Vivo

In primary human prostate cancer cells-derived from castration-resistant prostate cancer patients, WM-3835 potently inhibited cell viability, proliferation, cell cycle progression, and in vitro cell migration.